Levetiracetam Versus Valproate in Idiopathic Generalized Tonic-clonic Seizures

PHASE4CompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

October 1, 2019

Study Completion Date

December 1, 2019

Conditions
Epilepsy, Idiopathic Generalized
Interventions
DRUG

Levetiracetam

Levetiracetam with initial dose of 500 mg per 12 hours which will be increased 500 mg/week to target dose of 2000 mg/day and the dose could be increased to 3000 mg/day if seizures recurred

DRUG

Valproate

Sodium valproate with initial dose of 500 mg/day which will be increased 500 mg/week to target dose of 1500 mg/day and the dose could be increased to 2000 mg/d if seizures recurred.

Trial Locations (1)

4815837477

Bu Ali Sina Hospital, Sari

All Listed Sponsors
lead

Mazandaran University of Medical Sciences

OTHER

NCT03940326 - Levetiracetam Versus Valproate in Idiopathic Generalized Tonic-clonic Seizures | Biotech Hunter | Biotech Hunter